Federal Contractor

ABBOTT RAPID DX NORTH AMERICA, LLC Federal Contract Obligations (Last 5 Years)

Federal procurement profile for ABBOTT RAPID DX NORTH AMERICA, LLC (CAGE 5C4F2, UEI P782RNU1NNK3) covering obligations, agencies, NAICS codes, and annual trends over the last 5 years.

ABBOTT RAPID DX NORTH AMERICA, LLC recorded $3.12 billion in obligated federal awards across 2,077 actions in the last 5 years, with an average action value of $1.50 million. Most obligations came from the Defense Logistics Agency and the Department of the Army, and the largest NAICS concentration was in in-vitro diagnostic substance manufacturing.

Generated at 03/21/2026

Analysis period: Last 5 years

Totals, counts, and trends reflect the provided FPDS analysis window for the last 5 years and may not align exactly by year due to rounding and reporting detail.

CAGE Code
5C4F2
UEI
P782RNU1NNK3
Total Obligated
3.12 billion
3,123,167,016.10
Award Actions
2,077
Average Action Value
1,503,691.38

About ABBOTT RAPID DX NORTH AMERICA, LLC federal contract activity

ABBOTT RAPID DX NORTH AMERICA, LLC (CAGE 5C4F2, UEI P782RNU1NNK3) received $3.12 billion across 2,077 FPDS-recorded awards during the last 5 years, with an average award value of $1.50 million. The vendor’s federal activity is heavily concentrated in diagnostic and medical supply-related procurement, consistent with its core product profile.

Agency mix and customer concentration

The Defense Logistics Agency is the dominant buyer, accounting for $1.43 billion and 1,755 awards, indicating a high-volume supply relationship. The Department of the Army is the next-largest customer by dollars at $1.35 billion but with only 9 awards, showing a small number of very large obligations; the Office of the Assistant Secretary for Preparedness and Response adds a smaller but material $257.14 million tied to health preparedness procurement.

Industry profile based on NAICS activity

Contracting is centered on NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, which represents $2.44 billion and 436 awards. NAICS 325412, Pharmaceutical Preparation Manufacturing, adds $661.46 million, while NAICS 423450, Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, accounts for 1,461 awards but only $16.98 million, suggesting a large tail of lower-dollar distribution or resale activity.

Annual contract trend over the analysis window

Obligations were extremely elevated in 2021 and 2022, at $1.42 billion and $1.70 billion respectively, then fell sharply in 2023 to $2.13 million and remained low in 2024 and 2025. Award counts stayed relatively high in each year, which indicates continued procurement activity even as obligated dollars normalized materially after the peak period.

How to interpret this page

This summary is based on FPDS-observed obligations and award counts associated with the vendor over the last 5 years. Agency, NAICS, and annual rankings reflect the provided aggregates; no attempt was made to infer unreported contract scope, pricing, or performance beyond the recorded totals.

Top Agencies

SELECT
    agency_id,
    agency_name,
    total_obligated,
    award_count,
    formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
    SELECT
        content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
        anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
        sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
        count() AS award_count
    FROM fpds.data
    WHERE
        contract_type = 1
        AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '5C4F2'
        AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
        AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
    GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10
Agency ID Agency Name Total Obligated Readable Award Actions
97AS DEFENSE LOGISTICS AGENCY 1,425,663,393.58 1.43 billion 1,755
2100 DEPT OF THE ARMY 1,348,435,528.00 1.35 billion 9
7505 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE 257,139,696.72 257.14 million 5
7527 INDIAN HEALTH SERVICE 55,439,276.05 55.44 million 18
3600 VETERANS AFFAIRS, DEPARTMENT OF 24,216,566.14 24.22 million 196
7012 U.S. IMMIGRATION AND CUSTOMS ENFORCEMENT 8,996,804.00 9.00 million 17
1544 U.S. MARSHALS SERVICE 946,293.12 946.29 thousand 10
1540 FEDERAL PRISON SYSTEM / BUREAU OF PRISONS 690,840.35 690.84 thousand 16
1900 STATE, DEPARTMENT OF 659,966.65 659.97 thousand 30
97DH DEFENSE HEALTH AGENCY (DHA) 503,212.00 503.21 thousand 2

Insight

Over the last 5 years, ABBOTT RAPID DX NORTH AMERICA, LLC (CAGE 5C4F2) obligated $3.12 billion across 2,077 awards, with funding highly concentrated in two agencies. The Defense Logistics Agency accounted for $1.43 billion and 1,755 awards, while the Department of the Army obligated $1.35 billion across only 9 awards, indicating a mix of high-volume transactional buying and a small number of very large awards. All other agencies were materially smaller, led by the Office of Assistant Secretary for Preparedness and Response at $257.14 million, with the remaining agencies each below $56 million.

Top NAICS

SELECT
    naics_code,
    naics_name,
    total_obligated,
    award_count,
    formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
    SELECT
        content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
        anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
        sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
        count() AS award_count
    FROM fpds.data
    WHERE
        contract_type = 1
        AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '5C4F2'
        AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
        AND content__award__productOrServiceInformation__principalNAICSCode != ''
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
    GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10
NAICS Code Description Total Obligated Readable Award Actions
325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING 2,443,470,379.93 2.44 billion 436
325412 PHARMACEUTICAL PREPARATION MANUFACTURING 661,455,439.25 661.46 million 142
423450 MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS 16,983,161.26 16.98 million 1,461
334516 ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING 632,686.54 632.69 thousand 17
511210 SOFTWARE PUBLISHERS 387,704.48 387.70 thousand 10
339113 SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING 96,004.00 96.00 thousand 2
334510 ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS MANUFACTURING 91,469.00 91.47 thousand 4
339112 SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING 26,600.00 26.60 thousand 1
325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 12,864.64 12.86 thousand 1
621511 MEDICAL LABORATORIES 10,707.00 10.71 thousand 1

Insight

Over the last 5 years, Abbott Rapid DX North America, LLC’s obligations are highly concentrated in NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, which accounts for $2.44 billion of $3.12 billion total obligated, across 436 awards. NAICS 325412, Pharmaceutical Preparation Manufacturing, is the second-largest category at $661.46 million, indicating a strong secondary concentration in adjacent life sciences manufacturing. Although NAICS 423450 has the highest award count at 1,461, it represents only $16.98 million in obligated value, suggesting a lower-dollar, higher-transaction procurement pattern outside the core manufacturing categories.

Annual Trend

SELECT
    year,
    total_obligated,
    award_count,
    formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
    SELECT
        toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
        sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
        count() AS award_count
    FROM fpds.data
    WHERE
        contract_type = 1
        AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '5C4F2'
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
    GROUP BY year
)
ORDER BY year DESC
Year Total Obligated Readable Award Actions
2025 1,150,402.70 1.15 million 274
2024 128,835.65 128.84 thousand 402
2023 2,132,216.40 2.13 million 436
2022 1,695,570,008.06 1.70 billion 482
2021 1,424,185,553.29 1.42 billion 483

Insight

ABBOTT RAPID DX NORTH AMERICA, LLC’s obligations over the last 5 years are highly concentrated in FY 2021 and FY 2022, which together account for nearly all of the reported $3.12 billion total. Those two years drove the vendor’s annual activity above $1.4 billion and $1.7 billion respectively, followed by a sharp drop to low millions or less in FY 2023 through FY 2025. Award volume remained relatively steady across the period, ranging from 274 to 483 awards per year, indicating that the volatility is driven primarily by award value rather than award count.

Use FPDS Query for deeper contractor analysis

Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.

Continue from this last 5 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.